Increased Excretion of Urinary 20-HETE in Rats With Cyclosporine-Induced Nephrotoxicity
スポンサーリンク
概要
- 論文の詳細を見る
The present study examined the contribution of 20-hydroxy-5,8,11,14-eicosatetraenoic acid (20-HETE) in cyclosporine A (CsA)-induced renal nephrotoxicity. Treatment of rats with CsA (50 mg/kg) for 9 days induced renal damage as indicated by marked increase in urine flow (from 9.0 ± 0.3 ml/day to 46.6 ± 7.1 ml/day) and a 3 – 5-fold rise in blood urea nitrogen (BUN) levels. The urinary excretion of 20-HETE increased from 164 ± 5 ng/day (N = 5) to 2432 ± 290 ng/day (N = 5, P<0.01) after 9 days of CsA treatment. The increase in the urinary excretion of 20-HETE in the CsA treated rats was highly correlated with the increase in BUN levels (r = 0.819, P<0.001) and urine volume (r = 0.832, P<0.001). Immunohistochemical examination of kidney revealed that expression of cytochrome P450 4A (CYP4A) protein was markedly enhanced in the proximal tubules of CsA-treated rats. These results indicate that CsA-induced nephrotoxicity in rats is associated with a marked elevation in the renal production of 20-HETE and that 20-HETE may contribute to the pathophysiological condition of CsA-induced nephrotoxicity.
- 社団法人 日本薬理学会の論文
- 2005-01-20
著者
-
SAKURAI Takanobu
Medicinal Research Laboratory, Taisho Pharmaceutical Co., Ltd
-
Ishimoto Tsuyoshi
Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Roman Richard
Department of Physiology, Medical College of Wisconsin
-
Taniguchi Kazuo
Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
SEKI Takayuki
Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd.
-
YASUDA Yoshiko
Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd.
-
DOI Mariko
Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd.
-
SATO Mariko
Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd.
-
MIYATA Noriyuki
Medicinal Research Laboratories, Taisho Pharmaceutical Co., Ltd.
-
Doi Mariko
Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Roman Richard
Department Of Physiology Medical College Of Wisconsin
-
Seki Takayuki
Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Seki Takayuki
Medicinal Pharmacology Laboratory Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Yasuda Yoshiko
Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Sato Mariko
Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Roman Richard
Department Of Physiology And Medicine And Kidney Disease Center Medical College Of Wisconsin
-
Miyata Noriyuki
Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Miyata Noriyuki
Medicinal Pharmacology Laboratory Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
-
Sakurai Takanobu
Medicinal Research Laboratories Taisho Pharmaceutical Co. Ltd.
関連論文
- STAT6-mediated signaling in Th2-dependent allergic asthma : critical role for the development of eosinophilia, airway hyper-responsiveness and mucus hypersecretion, distinct from its role in Th2 differentiation
- PE-187 The Interaction of NO and 20-HETE in the Reduction of Cerebral Blood Flow Following Subarachnoid Hemorrhage in Rats(Cerebrovascular circulation/Stroke-2 (IHD) PE32,Poster Session (English),The 70th Anniversary Annual Scientific Meeting of the Japan
- Increased Excretion of Urinary 20-HETE in Rats With Cyclosporine-Induced Nephrotoxicity
- Role of 20-hydroxyeicosatetraenoic acid (20-HETE) in vascular system
- Cytochrome P450 4A Isoform Inhibitory Profile of N-Hydroxy-N'-(4-butyl-2-methylphenyl)-formamidine (HET0016), a Selective Inhibitor of 20-HETE Synthesis(Pharmacology)
- Suppression of AGE Precursor Formation Following Unilateral Ureteral Obstruction in Mouse Kidneys by Transgenic Expression of α-Dicarbonyl/L-Xylulose Reductase